Significant improvements in inflammatory biomarkers were induced by an integrase inhibitor-based regimen compared with a non-nucleoside reverse transcriptase inhibitor-based regimen. This favorable effect on immune activation may affect vascular inflammation. However, it is unknown whether these benefits are linked to clinical outcomes.
Learn more about ART integrase inhibitor-based regimens.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Michael Stuart Bronze, Enrico Brunetti. Fast Five Quiz: HIV Infection and Inflammation - Medscape - Aug 10, 2023.